Form 4 · Filed Jul 17, 2026, 08:15 PM UTC
CPRX/CATALYST PHARMACEUTICALS, INC.
Sundaram Preethi — Chief Strategy Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
10 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | D | other | 54,804 | $32 | $1,726,326 | 0 |
| Jul 15, 2026 | D | other | 225,000 | — | — | 0 |
| Jul 15, 2026 | D | other | 67,500 | — | — | 0 |
| Jul 15, 2026 | D | other | 68,000 | — | — | 0 |
| Jul 15, 2026 | D | other | 143,193 | — | — | 0 |
| Jul 15, 2026 | D | other | 137,553 | — | — | 0 |
| Jul 15, 2026 | D | other | 106,873 | — | — | 0 |
| Jul 15, 2026 | D | other | 6,855 | — | — | 0 |
| Jul 15, 2026 | D | other | 11,206 | — | — | 0 |
| Jul 15, 2026 | D | other | 32,257 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001161697-26-000182